| For: | Matsuda M. Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma. World J Hepatol 2015; 7(30): 2933-2939 [PMID: 26730272 DOI: 10.4254/wjh.v7.i30.2933] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i30/2933.htm |
| Number | Citing Articles |
| 1 |
B.G. Tillman, J.D. Gorman, J.M. Hru, M.H. Lee, M.C. King, C.B. Sirlin, R.M. Marks. Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening. Clinical Radiology 2018; 73(5): 485 doi: 10.1016/j.crad.2017.11.013
|
| 2 |
Katsuaki Tanaka, Masayuki Nakano, Shin Maeda, Hiroyuki Fukuda, Tomohiro Ishii, Kazushi Numata, Yoshiteru Hao. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(17): 3111-3121 doi: 10.3748/wjg.v23.i17.3111
|
| 3 |
Masanori Matsuda. 10. Surgical Treatment of Hepatocellular Carcinoma. Japanese Journal of Radiological Technology 2017; 73(4): 319 doi: 10.6009/jjrt.2017_JSRT_73.4.319
|
